Cargando…
Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics
Fungal keratitis, an ocular fungal infection, is one of the leading causes of monocular blindness. Natamycin has long been considered the mainstay drug used for treating fungal keratitis and is the only US Food and Drug Administration (USFDA)-approved drug, commercially available as a topical 5% w/v...
Autores principales: | Mascarenhas, Mabel, Chaudhari, Pinal, Lewis, Shaila A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329963/ https://www.ncbi.nlm.nih.gov/pubmed/37289410 http://dx.doi.org/10.1007/s12325-023-02541-x |
Ejemplares similares
-
Cyclodextrin–Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of Natamycin
por: Lorenzo-Veiga, Blanca, et al.
Publicado: (2019) -
Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization
por: Khames, Ahmed, et al.
Publicado: (2019) -
Ocular Drug Delivery: Advancements and Innovations
por: Tian, Bo, et al.
Publicado: (2022) -
Microneedle-based ocular drug delivery systems – recent advances and challenges
por: Gadziński, Piotr, et al.
Publicado: (2022) -
Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment
por: Hosny, Khaled M., et al.
Publicado: (2021)